EUVIMEDEUVIMED entdecken
Open Access

Russian eligibility criteria prescribing menopausal hormonal hormones therapy for patients with cardiovascular and metabolic diseases. Consensus document of the Russian Cardiological Society, Russian Society of Obstetricians and Gynecologists, Russian Association of Endocrinologists, Eurasian Association of Therapists, Association of Phlebologists of Russia

E V Shlyakhto, G T Sukhikh, V N Serov, I I Dedov, G P Arutyunov, I A Suchkov, Ya A Orlova, E N Andreeva, S V Yureneva, I S Yavelov, M I Yarmolinskaya, S V Villevalde und 7 weitere

Problems of Endocrinology · 2023

DOI: 10.14341/probl13394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Problems of Endocrinology, 2023. Verfasst von E V Shlyakhto und 18 weiteren Autor:innen. Beteiligte Einrichtung: National Medical Research Center named after V.A. Almazov. Hauptthemen laut MEDLINE: Estrogen Replacement Therapy, Metabolic Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Menopausal symptoms can disrupt the life course of women at the peak of their career and family life. Currently, the most effective treatment for these manifestations is menopausal hormone therapy (MHT). The presence of cardiovascular and metabolic diseases in itself does not exclude the possibility of prescribing MHT to relieve menopausal symptoms and improve quality of life. However, often an obstacle to the use of this type of hormonal therapy is the fear of doctors who are afraid of doing more harm to patients than good. Caution is especially important when it comes to women with underlying health conditions. Moreover, it should be recognized that there is a lack of high-quality research regarding the safety of MHT for major chronic non-infectious diseases and common comorbid conditions. The presented consensus document analyzed all currently available data obtained from clinical trials of various designs and created a set of criteria for the acceptability of prescribing MHT to women with concomitant cardiovascular and metabolic diseases. Based on the presented document, doctors of various specialties who advise women in menopause will receive an accessible algorithm that will allow them to avoid potentially dangerous situations and reasonably prescribe MHT in real practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Estrogen Replacement TherapyMetabolic DiseasesHumansFemaleGynecologistsEndocrinologistsObstetriciansQuality of LifeMenopauseHormones

Substanzen

Hormones

Autor:innen und Institutionen

  • National Medical Research Center named after V.A. Almazov.
  • National Medical Research Center for obstetrics, gynecology and perinatology named after academician V.I. Kulakov.
  • Endocrinology Research Center.
  • Russian National Research Medical University named after N.I. Pirogov.
  • Ryazan State Medical University I.P. Pavlova.
  • Medical Research and Educational Center of Moscow State University named after M.V. Lomonosov.

Zitieren

APA

Shlyakhto, E. V., Sukhikh, G. T., Serov, V. N., Dedov, I. I., Arutyunov, G. P., Suchkov, I. A., Orlova, Y. A., Andreeva, E. N., Yureneva, S. V., Yavelov, I. S., Yarmolinskaya, M. I., Villevalde, S. V., Grigoryan, O. R., Dudinskaya, E. N., Ilyukhin, E. A., Koziolova, N. A., Sergienko, I. V., Smetnik, A. A., & Tapilskaya, N. I. (2023). Russian eligibility criteria prescribing menopausal hormonal hormones therapy for patients with cardiovascular and metabolic diseases. Consensus document of the Russian Cardiological Society, Russian Society of Obstetricians and Gynecologists, Russian Association of Endocrinologists, Eurasian Association of Therapists, Association of Phlebologists of Russia. Problems of Endocrinology. https://doi.org/10.14341/probl13394

Vancouver

Shlyakhto EV, Sukhikh GT, Serov VN, Dedov II, Arutyunov GP, Suchkov IA, et al. Russian eligibility criteria prescribing menopausal hormonal hormones therapy for patients with cardiovascular and metabolic diseases. Consensus document of the Russian Cardiological Society, Russian Society of Obstetricians and Gynecologists, Russian Association of Endocrinologists, Eurasian Association of Therapists, Association of Phlebologists of Russia. Problems of Endocrinology. 2023. doi:10.14341/probl13394

BibTeX
@article{Shlyakhto2023,
  author = {Shlyakhto, E V and Sukhikh, G T and Serov, V N and Dedov, I I and Arutyunov, G P and Suchkov, I A and Orlova, Ya A and Andreeva, E N and Yureneva, S V and Yavelov, I S and Yarmolinskaya, M I and Villevalde, S V and Grigoryan, O R and Dudinskaya, E N and Ilyukhin, E A and Koziolova, N A and Sergienko, I V and Smetnik, A A and Tapilskaya, N I},
  title = {Russian eligibility criteria prescribing menopausal hormonal hormones therapy for patients with cardiovascular and metabolic diseases. Consensus document of the Russian Cardiological Society, Russian Society of Obstetricians and Gynecologists, Russian Association of Endocrinologists, Eurasian Association of Therapists, Association of Phlebologists of Russia},
  journal = {Problems of Endocrinology},
  year = {2023},
  doi = {10.14341/probl13394}
}
Kostenlos starten →